AOD-9604 Overdose and Accidental Excess Dose: Recognition, Risks, and Clinical Management At a glance Peptide identity / modified C-terminal fragment of hGH (residues 176-191) with a tyrosine substitution FDA approval status / not FDA-approved
This targeted activation makes ARA-290 fundamentally different from broad-spectrum anti-inflammatories or standard pain medications that mask symptoms without addressing the underlying damage
Regulatory Status 5-Amino-1MQ is supplied strictly for in vitro and preclinical research purposes
Skin Rejuvenation & Anti-Aging (Collagen & Elastin Boosting) Dosage: 25 mg per day (subcutaneous injection) or 0.1%2% topical cream Cycle: Continuous use for 812 weeks, with a 4-week break Administration: Injectable: Best taken before bed for cellular repair Topical: Apply twice daily for skin improvement Stacking: With Epitalon for telomere extension and longevity With Thymosin Beta-4 (TB-500) for wound healing synergy With MOTS-c for mitochondrial skin regeneration Expected Benefits: Increased collagen and elastin production Reduction in wrinkles, fine lines, and sagging Improved skin hydration, firmness, and texture 2
Reconstituted solutions should be stored under validated laboratory conditions and discarded according to internal SOPs and applicable research-waste rules
